FORMULATION AND EVALUATION OF LIQUID ORAL SUSPENSION OF PARACETAMOL USING NEWLY ISOLATED AND CHARACTERIZED HYGROPHILA SPINOSA SEED MUCILAGE AS SUSPENDING AGENT

Objective: The objective of this study was to demonstrate and evaluate the suspending property of newly isolated, purified, and characterized Hygrophila spinosa seed mucilage in liquid oral suspensions of paracetamol.Methods: Isolation of mucilage from H. spinosa seeds was done by maceration process, and then it was characterized by phytochemical screening, solubility, pH, swelling index, flow rate, viscosity, loss on drying, and cytotoxicity. The characterized mucilage was then used as a suspending agent for the preparation of suspensions containing paracetamol as a model drug. The prepared formulations were then evaluated for different parameters such as sedimentation volume, redispersibility, flow rate, pH, viscosity, and other physical examination.Results: The isolated mucilage is a polysaccharide with no impurities and nontoxic in nature. It has got enough swellability and good viscosity. The prepared suspensions were evaluated, and the results such as sedimentation volume, redispersibility, flow rate, pH, viscosity, and other physical examination showed its suspending property.Conclusion: The study revealed that a lesser amount of H. spinosa seed mucilage can produce a good suspension. By this study, it could be find out that a 1/5th quantity of mucilage (0.2%) is only required to prepare a suspension of paracetamol when compared with suspensions prepared of compound tragacanth (1%) and sodium carboxymethyl cellulose (1%) as suspending agents. Thus, by this study, it can be stated that the mucilage from H. spinosa possesses all the criteria needed by a standard suspending agent.Â

FORMULATION AND EVALUATION OF ANTIMICROBIAL GELS FOR THE TREATMENT OF PARONYCHIA

Objective: The aim of the study was to design and develop a gel based drug delivery system containing combinational drugs (ketoconazole, neomycin sulphate and diclofenac) for the effective treatment of Paronychia.Methods: The drugs used are ketoconazole, neomycin sulphate and diclofenac. The first two drugs provide an antifungal and antibacterial action and the last drug with a pain relieving effect. Two formulations of gels F1 and F2 were prepared using polymers like carbopol 934 and xanthan gum respectively. The amounts of drugs and other ingredients were kept as constant in both formulations. The prepared formulations were then evaluated by visual examination, pH, drug content, spredability, extrudability, drug release study, in vitro antibacterial study, in vitro antifungal study, stability studies and in vivo antibacterial study.Results: The obtained results were analyzed and compared. All the test results were within the accepted limit. The physicochemical properties of the gels were assessed and it was found that the two formulations have enough gel consistency with good spreadability and extrudability. The drug content and drug release studies of the prepared gels were done and the results showed that the all the three drugs were properly loaded into the gel system, with good drug release profile. The antimicrobial activities of the formulated gels were proved by both in vitro antifungal and antibacterial studies. The in vivo antibacterial studies revealed a significant reduction in bacterial count in wistar rats treated with prepared gel when compared with standard drug solution. From among all the developed formulations, F1 formulation with carbopol 934 has got a slight superior property when compared with formulation F2 xanthan gum as gelling agent.Conclusion: On the basis of the evaluation studies it was concluded that the drugs (ketoconazole, neomycin sulphate and diclofenac) were successfully incorporated into the different topical gel preparations with good physicochemical properties and antimicrobial activity. Therefore, it was concluded that our formulae could be very promising topical alternative for the treatment of Paronychia

An Efficient Strategy for the General Synthesis of 3-aryl Substituted Pyrazolo[5,1-c][1,4]Benzoxazines and Pyrazolo[1,5-a][1,4]Benzodiazepin- 6(4H)-ones

An efficient strategy for the general synthesis of 3-aryl substituted pyrazolo[5,1-c][1,4]benzoxazines and pyrazolo[1,5-a][1,4]benzodiazepin-6(4H)-ones has been developed using intramolecular 1,3-dipolar cycloaddition. The hydrazonoyl chloride, the precursor of the cycloadduct, is accessed easily through a two-step reaction carried out in one-pot. It is then used without purification for the base induced formation of the nitrilimine, which undergoes subsequent in situ intramolecular cycloaddition with an alkyne to afford the desired product. The reaction protocol has also been applied in bis-heteroannulation and in the synthesis of uracil derivatives of biological interest. The operational simplicity of the process, the use of cheap starting materials, and the relatively short reaction times required make the process convenient and practica